A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER OUTPATIENT PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH EPILEPSY WITH A PREDICTABLE SEIZURE PATTERN.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Epilepsy
  • Age: Between 12 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Participant has diagnosis of focal or generalized epilepsy or combined focal and generalized epilepsy with a documented history of predictable episodes of prolonged seizures.
    2. Participant has experienced at least 4 predictable epis

You may not be eligible for this study if the following are true:

    1. Participant has any medical or psychiatric condition that could jeopardize or would compromise the study participant’s ability to participate in this study.
    2. Participant has a current history of alcohol or drug use disorder within


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.